iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/11830759
SB-236057-A: a selective 5-HT1B receptor inverse agonist - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Winter;7(4):433-44.
doi: 10.1111/j.1527-3458.2001.tb00209.x.

SB-236057-A: a selective 5-HT1B receptor inverse agonist

C Roberts  1 , J Watson, G W Price, D N Middlemiss
Affiliations
Review

SB-236057-A: a selective 5-HT1B receptor inverse agonist

C Roberts et al. CNS Drug Rev. 2001 Winter.

Abstract

5-HT1B autoreceptors are involved in the control of extracellular 5-HT levels from both the terminal and cell body regions of serotonergic neurons. In this manuscript we review the pharmacological and pharmacokinetic data available for the selective and potent 5-HT1B receptor inverse agonist, SB-236057-A (1'-ethyl-5-(2'-methyl-4'-(5-methyl-1,3,4-oxadiazolyl-2-yl)biphenyl-4-carbonyl)-2,3,6,7-tetrahydrospiro (furo[2,3-f]indole-3,4'-piperidine) hydrochloride). SB 236057-A has been shown to have high affinity for human 5-HT1B receptors (pK(i) = 8.2) and displays 80 or more fold selectivity for the human 5-HT1B receptor over other 5-HT receptors and a range of additional receptors, ion channels and enzymes. In functional studies at human 5-HT1B receptors SB-236057-A displayed inverse agonism (pA(2) = 8.9) using [(35)S]GTPgammaS binding, and silent antagonism (pA(2) = 9.2) using cAMP accumulation. SB-236057-A also acted as an antagonist at the 5-HT terminal autoreceptor as measured by [3H]5-HT release from electrically stimulated guinea pig and human cortical slices. In the guinea pig, pharmacokinetic analysis demonstrated that SB-236057-A was bioavailable and according to in vivo pharmacodynamic assays it enters brain and has a long duration of action. Importantly no side effect liability was evident at relevant doses from anxiogenic, cardiovascular, sedative or migraine viewpoints. In vivo microdialysis studies demonstrated that SB-236057-A is an antagonist in the guinea pig cortex but has no effect on extracellular 5-HT levels per se. In contrast, SB-236057-A increased extracellular 5-HT levels in the guinea pig dentate gyrus. This increase in 5-HT release was comparable to that observed after 14 days of paroxetine administration. SB-236057-A has been a useful tool in confirming that, in either guinea pigs or humans, the terminal 5-HT autoreceptor is of the 5-HT1B subtype. It appears that acute 5-HT1B receptor blockade, by virtue of increased 5-HT release in the dentate gyrus, may provide a rapidly acting antidepressant.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Blier P, de Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 1987;7:24S–35S. - PubMed
    1. Blier P, de Montigny C, Chaput Y. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 1990;51 (Suppl 12): 14–20. - PubMed
    1. Blier P, Serrano A, Scatton B. Differential responsiveness of the rat dorsal and median raphe 5‐HT systems to 5‐HT receptor agonists and pCA. Synapse 1990;5:120–133. - PubMed
    1. Buhlen M, Fink K, Boing C, Gothert M. Evidence for presynaptic location of inhibitory 5‐HT1Dα‐like autoreceptors in the guinea pig cortex. Naunyn Schmiedeberg's Arch Pharmacol 1996;353:281–289. - PubMed
    1. Cooper J, Greenslade RG, Mitchel SN. Selective 5‐HT1B receptor antagonists potentiate the effects of fluoxetine on 5‐HT release in the guinea‐pig hypothalamus In: Rollema H, Abercrombie E, Sulzer D, Zackheim J. (eds). Monitoring molecules in neuroscience, 1999;263–264.

MeSH terms

LinkOut - more resources